Extracorporeal membrane oxygenation (ECMO): An option for cardiac reccovery from advanced cardiogenic shock

Ali Ghodsizad, Kai Singbartl, Matthias Loebe, Mohamed Zeriouh, Arjang Ruhparwar, April Grant, Ali El-Banayosy, M. M. Koerner

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Venoarterial (VA) ECMO has been used as a viable therapeutic option for advanced cardiogenic shock as a bridge to recovery (BTR) or bridge to next decision (BTD). Our group performed a retrospective review of data from 155 patients from our single center cohort treated with VA ECMO for advanced cardiogenic shock. After successful ECMO treatment, the one year survival rate of patients with ischemic heart disease was 73.7 %, and the one year survival for patients with non-ischemic heart disease was 75%.

Original languageEnglish (US)
Pages (from-to)E274-E277
JournalHeart Surgery Forum
Volume20
Issue number6
DOIs
StatePublished - Dec 2017

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Extracorporeal membrane oxygenation (ECMO): An option for cardiac reccovery from advanced cardiogenic shock'. Together they form a unique fingerprint.

  • Cite this

    Ghodsizad, A., Singbartl, K., Loebe, M., Zeriouh, M., Ruhparwar, A., Grant, A., El-Banayosy, A., & Koerner, M. M. (2017). Extracorporeal membrane oxygenation (ECMO): An option for cardiac reccovery from advanced cardiogenic shock. Heart Surgery Forum, 20(6), E274-E277. https://doi.org/10.1532/hsf.1635